(Press-News.org) What if doctors could guide life-saving treatments through the body using only a magnet?
An interdisciplinary collaboration at the University of Pittsburgh’s Swanson School of Engineering is bringing that concept closer to reality with the development of silk iron microparticles (SIMPs)—tiny, magnetic, and biodegradable carriers designed to precisely deliver drugs and treatments to sites in the body like aneurysms or tumors.
Led by Pitt alumna Ande Marini (BioE PhD ‘25), now a postdoctoral scholar in cardiothoracic surgery at Stanford University, David Vorp, John A. Swanson Professor of bioengineering, and Justin Weinbaum, research assistant professor of bioengineering, the team’s results, “Chemical Conjugation of Iron Oxide Nanoparticles for the Development of Magnetically Directable Silk Particles” (doi.org/10.1021/acsami.4c17536), were published in the February edition of ACS Applied Materials & Interfaces.
Marini’s team was inspired to develop these particles as part of their lab’s mission to improve treatments for abdominal aortic aneurysms (AAA), which can be life-threatening if left untreated and lead to nearly 10,000 deaths per year. By enabling early stage, noninvasive delivery of regenerative therapies using extracellular vesicles—membrane capsules that can facilitate intercellular communication—they hope to ultimately reduce the need for surgical intervention for AAA.
“We want to find a way to deliver extracellular vesicles to the site of an abdominal aortic aneurysm in the least invasive way possible.” Vorp said. “We envisioned that we could inject extracellular vesicles onto a carrier and then somehow guide the carrier to the outside of the aortic wall, so we came up with the idea of using magnetic attraction.”
To create the magnetic particles, the team collaborated with Mostafa Bedewy, associate professor of mechanical engineering & materials science at the Swanson School, and Golnaz Tomaraei (IE PhD ‘23), Pitt alumna and Bedewy’s former PhD student. The duo’s expertise in nanomaterials and nanofabrication helped the team create the magnetic nanoparticles, which are roughly one-hundred-thousandth the width of a human hair. At that extremely small scale, nanomaterials can be manipulated to take on unique properties, such as magnetic responsiveness.
“Our role was to synthesize magnetic nanoparticles with the right properties and bond them to the silk so they’d stay attached during movement,” Bedewy said. “You can think of it like towing cargo—we created the particles to carry drugs, and the nanoparticles are the tow hook.”
Magnetically directable materials have previously been utilized for a variety of medical applications, but the team’s unique approach was to create the SIMPs by chemically conjugating the magnetic nanoparticles to silk—an FDA approved, biocompatible material—using the chemical compound glutathione.
“We bridged biomaterials and chemical conjugation to create particles that could be magnetically guided,” Marini said. “By chemically bonding iron oxide nanoparticles to the regenerated silk fibroin, we enhanced their magnetic movability so we can potentially localize them externally to a site of interest in the body. ”
This research opens the door to a wide range of future applications—from targeted cancer therapies to regenerative treatments for cardiovascular disease. With the ability to magnetically guide the particles, the next step is loading them with therapeutic cargo.
“With this paper, we’re showing that we can create an empty carrier that can be magnetically moved,” Marini said. “The next step is figuring out what kind of cargo we can load—regenerative factors, drugs, or other materials people want to magnetically localize. Whether it’s delivering cancer drugs with fewer side effects or slowing down tissue degradation in aneurysms, this technology has broad potential for regenerative medicine.”
At the nanoscale, these findings also help Bedewy’s team continue to tailor the particles’ molecular structure and control their drug release rates for enhanced biomedical applications.
“We're trying to create a toolbox of treatments, and in materials science, there's a lot of room for making more tools that can be useful for medical doctors and bioengineers to help create different ways of resolving problems in the body,” Bedewy said. “This is an exciting project where people with very different sets of expertise came together to solve a problem and produce an outcome that could potentially have an immense impact on human lives.”
END
Making magnetic biomaterials
Pitt engineers develop magnetically navigable microparticles for targeted drug delivery
2025-04-29
ELSE PRESS RELEASES FROM THIS DATE:
Synchrotron in a closet: Bringing powerful 3D X-ray microscopy to smaller labs
2025-04-29
Images
For the first time, researchers can study the microstructures inside metals, ceramics and rocks with X-rays in a standard laboratory without needing to travel to a particle accelerator, according to a study led by University of Michigan engineers.
The new technique makes 3D X-ray diffraction—known as 3DXRD—more readily accessible, potentially enabling quick analysis of samples and prototypes in academia and industry, as well as providing more opportunities for students.
3DXRD reconstructs 3D images using X-rays taken at multiple angles, similar to a CT scan. Instead of the imaging device rotating about ...
Multiscale fibrous reinforcements yield high-performance construction composite
2025-04-29
A recent study published in Engineering by Peizhao Zhou and Peng Feng from Tsinghua University introduces a novel construction material—flexible ultra-high performance reinforced cementitious composite (FHPRC). This material holds great potential for revolutionizing the construction industry with its excellent mechanical properties.
The research focuses on the concept of multiscale fibrous reinforcements in cementitious matrices. By carefully tailoring the types, sizes, and volume fractions of fibers, the researchers optimized the tensile ...
Using “shallow shadows” to uncover quantum properties
2025-04-29
It would be difficult to understand the inner workings of a complex machine without ever opening it up, but this is the challenge scientists face when exploring quantum systems. Traditional methods of looking into these systems often require immense resources, making them impractical for large-scale applications.
Researchers at UC San Diego, in collaboration with colleagues from IBM Quantum, Harvard and UC Berkeley, have developed a novel approach to this problem called “robust shallow shadows.” This technique allows scientists to extract essential information from quantum systems more efficiently and accurately, even in the presence of real-world noise and imperfections.
Imagine ...
China’s EV ultrafast charging stations: Challenges, solutions, and costs
2025-04-29
A new study published in Engineering delves into the future of ultrafast charging stations for electric vehicles (EVs) in China, exploring charging patterns, grid impacts, solutions, and upgrade costs. As the global EV market continues to expand rapidly, with China leading the way in EV adoption, understanding these aspects is crucial for sustainable development.
The research team, led by Yang Zhao, Xinyu Chen and Michael B. McElroy, analyzed real-world charging data from over 15,000 EVs at ...
AACR: New CAR T cell therapy benefits patients with advanced thyroid cancers
2025-04-29
Phase I trial demonstrates lasting responses and encouraging safety profile in two aggressive thyroid cancer subtypes, suggesting further progress for CAR T cell therapy in solid tumors
One patient experienced a complete response, and one patient had a partial response
This type of cancer has limited treatment options, and most patients have a poor prognosis of six months or less
AIC100 is a CAR T cell therapy that targets the ICAM-1 protein on tumor cells
ABSTRACT: CT206
CHICAGO, APRIL 29, 2025 ― A new chimeric antigen receptor (CAR) T cell therapy called AIC100, which targets the ICAM-1 protein, demonstrated encouraging responses and an acceptable safety ...
AcrOSS platform: Advancing safe UAS operations in critical areas
2025-04-29
In a recent development in the field of unmanned aircraft systems (UAS), a research team from the University of Salento in Italy has designed and tested a novel platform named AcrOSS. The details of this platform are published in Engineering, aiming to enhance the safety and efficiency of UAS operations in critical areas.
The widespread use of UAS in civil airspace, especially for beyond visual line-of-sight (BVLOS) operations, faces numerous challenges. The AcrOSS project, funded by the Italian Ministry for Research, focuses on developing ...
Quantum computing paves the way for low-carbon building operations
2025-04-29
A new study published in Engineering presents an innovative approach to building energy management that combines quantum computing with model predictive control (MPC), aiming to enhance energy efficiency and drive decarbonization in buildings.
Buildings are major energy consumers, contributing significantly to global energy use and greenhouse gas emissions. To address these issues, researchers Akshay Ajagekar and Fengqi You from Cornell University developed an adaptive quantum approximate optimization-based MPC strategy. This strategy is designed for buildings equipped with battery energy storage and renewable energy generation systems, such as photovoltaic (PV) panels.
The heart ...
HonorHealth Research Institute presents new findings in decades-long quest to conquer aggressive pancreatic cancer
2025-04-29
PHOENIX, Ariz. — April 30, 2025 — HonorHealth Research Institute’s new downtown Phoenix laboratory has produced its first study, centered on a promising new treatment for pancreatic cancer, one of the most aggressive and difficult to treat of all malignancies.
Study results were presented April 29 in Chicago at the annual meeting of the 58,000-member American Association for Cancer Research (AACR), the world’s largest professional organization of cancer investigators, caregivers and patient advocates.
Study findings indicate that a newly discovered drug, RMC-6236, also known as Daraxonrasib, is a powerful inhibitor of RAS (including KRAS, NRAS and HRAS). These ...
HonorHealth Research Institute is the first of 50 sites worldwide to treat a patient in a new clinical study aimed at melanoma
2025-04-29
SCOTTSDALE, Ariz. — April 29, 2025 — HonorHealth Research Institute recently treated the first patient in a 50-site international clinical trial that will test a new type of therapy aimed at difficult-to-treat melanoma, an aggressive type of skin cancer.
This new therapy targets PRAME, a peptide commonly found in melanoma tumors. The therapy uses the patient’s own manufactured and enhanced immune system T cells to create billions of new patient specific cells to attack melanoma, even after the cancer has spread to other parts of the body.
“We are excited about the potential of this new type of cellular therapy,” said Justin Moser, M.D., an associate ...
Surviving cancer, still suffering: Survey reveals gaps in follow‑up care
2025-04-29
Over 70% said mental health was not addressed during treatment
Less than a third had information about survivorship care
Northwestern oncologists are launching new survivorship clinic based on findings
Findings apply broadly to survivors of many cancers
CHICAGO --- More Americans are beating cancer than ever, yet many still grapple with treatment’s long shadow — especially on their mental health.
A new Northwestern Medicine study found most head-and-neck cancer survivors who underwent ...
LAST 30 PRESS RELEASES:
Higher cigarette taxes may improve childhood survival
Exercise can counter detrimental effects of cancer treatment
Too few ward nurses linked to longer hospital stay, readmission, and risk of death
Friendship bracelet: New technology connects neurodiverse groups of children
Forest in sync: Spruce trees communicate during a solar eclipse
Parents take a year to ‘tune in’ to their child’s feelings about starting school, research suggests
American Heart Association stands together with Arkansas and against the soda industry to reduce sugary drink consumption
AI-ECG tools can help clinicians identify heart issues early in women planning to have children
NIH’s initiative to prioritize human-based research a ‘big win for animals,’ says doctors group
Nearly one-quarter of e-Scooter injuries involved substance impaired riders
Age, previous sports experience, stronger predictors of performance in children than previous concussions, York U study finds
Dogs with meningiomas live longer with radiation therapy than surgery, Texas A&M researchers find
Pregnancy-related proteins in tumors linked to worse survival in female lung cancer patients
New study highlights success of financial toxicity tumor board in reducing cancer treatment costs
CAD/CAM shows clinical benefits in jaw reconstruction, reports Plastic and Reconstructive Surgery
Missed school is an overlooked consequence of climate change
Reasons why anxiety and depression promote low self-belief revealed
UMass Amherst graduate student’s discovery shows that even neutral molecules take sides when it comes to biochemistry
Electroactive biofiltration dynamic membrane: A new hope for wastewater treatment
Disparities in breast reconstruction persist after ACA, reports Plastic and Reconstructive Surgery
Making magnetic biomaterials
Synchrotron in a closet: Bringing powerful 3D X-ray microscopy to smaller labs
Multiscale fibrous reinforcements yield high-performance construction composite
Using “shallow shadows” to uncover quantum properties
China’s EV ultrafast charging stations: Challenges, solutions, and costs
AACR: New CAR T cell therapy benefits patients with advanced thyroid cancers
AcrOSS platform: Advancing safe UAS operations in critical areas
Quantum computing paves the way for low-carbon building operations
HonorHealth Research Institute presents new findings in decades-long quest to conquer aggressive pancreatic cancer
HonorHealth Research Institute is the first of 50 sites worldwide to treat a patient in a new clinical study aimed at melanoma
[Press-News.org] Making magnetic biomaterialsPitt engineers develop magnetically navigable microparticles for targeted drug delivery